436 related articles for article (PubMed ID: 25586212)
21. Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.
Braund TA; Palmer DM; Williams LM; Harris AWF
Psychol Med; 2020 Apr; 50(6):1032-1042. PubMed ID: 31023398
[TBL] [Abstract][Full Text] [Related]
22. Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder.
Korgaonkar MS; Rekshan W; Gordon E; Rush AJ; Williams LM; Blasey C; Grieve SM
EBioMedicine; 2015 Jan; 2(1):37-45. PubMed ID: 26137532
[TBL] [Abstract][Full Text] [Related]
23. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
[TBL] [Abstract][Full Text] [Related]
24. Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.
Gaspersz R; Lamers F; Kent JM; Beekman ATF; Smit JH; van Hemert AM; Schoevers RA; Penninx BWJH
J Psychiatr Res; 2017 Jan; 84():41-48. PubMed ID: 27693981
[TBL] [Abstract][Full Text] [Related]
25. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
Vaccarino AL; Evans KR; Sills TL; Kalali AH
Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
[TBL] [Abstract][Full Text] [Related]
26. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
[TBL] [Abstract][Full Text] [Related]
27. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
28. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?
Arns M; Etkin A; Hegerl U; Williams LM; DeBattista C; Palmer DM; Fitzgerald PB; Harris A; deBeuss R; Gordon E
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1190-200. PubMed ID: 25936227
[TBL] [Abstract][Full Text] [Related]
29. Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: An iSPOT-D report.
Braund TA; Palmer DM; Williams LM; Harris AW
Aust N Z J Psychiatry; 2019 Aug; 53(8):782-793. PubMed ID: 30880405
[TBL] [Abstract][Full Text] [Related]
30. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
[TBL] [Abstract][Full Text] [Related]
31. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ
J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427
[TBL] [Abstract][Full Text] [Related]
32. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
Grieve SM; Korgaonkar MS; Etkin A; Harris A; Koslow SH; Wisniewski S; Schatzberg AF; Nemeroff CB; Gordon E; Williams LM
Trials; 2013 Jul; 14():224. PubMed ID: 23866851
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
Weisler RH; Montgomery SA; Earley WR; Szamosi J; Lazarus A
Int Clin Psychopharmacol; 2012 Jan; 27(1):27-39. PubMed ID: 22027845
[TBL] [Abstract][Full Text] [Related]
34. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
Demyttenaere K; Andersen HF; Reines EH
Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
[TBL] [Abstract][Full Text] [Related]
35. Effects of heart disease on depression treatment: results from the COMED study.
Kerber KB; Wisniewski SR; Luther JF; Leuchter AF; D'Empaire I; Trivedi MH; Rush AJ
Gen Hosp Psychiatry; 2012; 34(1):24-34. PubMed ID: 22001552
[TBL] [Abstract][Full Text] [Related]
36. Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder.
Mittal D; Fortney JC; Pyne JM; Wetherell JL
J Clin Psychiatry; 2011 Nov; 72(11):1445-51. PubMed ID: 21208594
[TBL] [Abstract][Full Text] [Related]
37. Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
Sung SC; Wisniewski SR; Luther JF; Trivedi MH; Rush AJ;
J Affect Disord; 2015 Mar; 174():157-64. PubMed ID: 25497473
[TBL] [Abstract][Full Text] [Related]
38. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
Nelson JC
Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
[TBL] [Abstract][Full Text] [Related]
39. EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study.
Arns M; Gordon E; Boutros NN
Clin EEG Neurosci; 2017 Jan; 48(1):33-40. PubMed ID: 26674366
[TBL] [Abstract][Full Text] [Related]
40. Clinical features and drug induced side effects in early versus late antidepressant responders.
Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A
J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
